Position in NVS
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$27,172,740
+$2,578,768 QoQ
Shares Held
173,384
+7.7% QoQ
Ownership
0.009%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#94
of 1,603 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 55%
Shared 0%
None 45%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026CAPTRUST FINANCIAL ADVISORS holds $1,882,423,234 across 16 Drug Manufacturers - General names. NVS ranks #9 (1.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
1,817,391 | $457,328,271 | |
| 2 | LLY |
ELI LILLY & Co
|
308,951 | $370,565,128 | |
| 3 | MRK |
Merck & Co., Inc.
|
2,054,383 | $263,988,215 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
1,763,525 | $222,803,748 | |
| 5 | JNJ |
Johnson & Johnson
|
783,288 | $198,931,653 | |
| 6 | AMGN |
Amgen Inc
|
516,543 | $187,050,551 | |
| 7 | PFE |
Pfizer Inc
|
3,628,237 | $87,367,946 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
607,026 | $34,976,838 |
All Filings in NVS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $27,172,740 | 173,384 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $24,593,972 | 161,008 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $22,231,813 | 161,252 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $19,768,067 | 154,149 | Shares | Sole | 2025-11-19 | |
| 2025-06-30 | $18,304,577 | 151,265 | Shares | Sole | 2025-08-15 | |
| 2025-03-31 | $15,561,604 | 139,591 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $11,839,123 | 121,664 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $15,072,795 | 131,045 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $13,766,874 | 129,315 | Shares | Sole | 2024-08-15 | |
| 2024-03-31 | $12,263,526 | 126,781 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $14,248,785 | 141,119 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $14,298,291 | 140,372 | Shares | Sole | 2023-11-15 | |
| 2023-06-30 | $13,072,184 | 129,543 | Shares | Sole | 2023-08-15 | |
| 2023-03-31 | $10,519,924 | 114,347 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $9,984,824 | 110,062 | Shares | Sole | 2023-02-15 | |
| 2022-09-30 | $8,422,364 | 110,806 | Shares | Sole | 2022-11-16 | |
| 2022-06-30 | $8,108,878 | 95,929 | Shares | Sole | 2022-08-23 | |
| 2022-03-31 | $7,592,042 | 86,519 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $7,423,928 | 84,874 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $6,779,480 | 82,899 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $7,152,668 | 78,394 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $6,931,145 | 81,085 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $7,339,382 | 77,723 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $6,562,349 | 75,464 | Shares | Sole | 2020-11-17 | |
| 2020-06-30 | $6,673,824 | 76,412 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $6,015,304 | 72,957 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||